| 2.59 -0.34 (-11.6%) | 06-09 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.55  |
1-year : | 5.52 |
| Resists | First : | 3.9 |
Second : | 4.73 |
| Pivot price | 3.47 |
|||
| Supports | First : | 2.55 |
Second : | 2.12 |
| MAs | MA(5) : | 3.12 |
MA(20) : | 3.46 |
| MA(100) : | 3.55 |
MA(250) : | 5.71 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 6.5 |
D(3) : | 19.5 |
| RSI | RSI(14): 32.6 |
|||
| 52-week | High : | 17.18 | Low : | 2.1 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ HYPD ] has closed below the lower bollinger band by 12.3%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 20.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.95 - 2.98 | 2.98 - 2.99 |
| Low: | 2.51 - 2.54 | 2.54 - 2.56 |
| Close: | 2.55 - 2.61 | 2.61 - 2.64 |
Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.
Mon, 08 Jun 2026
Hyperion DeFi, Inc. Maintains 2026 Financial Guidance Despite Partnership Changes with Native Markets and Felix Markets - Quiver Quantitative
Mon, 08 Jun 2026
Hyperion DeFi Reiterates Guidance on Sunset of USDH and Felix Markets - The Manila Times
Sat, 06 Jun 2026
Hyperion DeFi to unwind $29 million in HYPE deals with Felix, Native Markets as USDH sunsets - The Block
Sat, 06 Jun 2026
Hyperion DeFi, Inc. Files Form 8-K With SEC – Common Stock Listed on NASDAQ Under Symbol HYPD - Minichart
Fri, 05 Jun 2026
Hyperion DeFi winds down USDH arrangements, to reposition ~800,000 HYPE tokens - TradingView
Fri, 05 Jun 2026
Hyperion DeFi (NASDAQ: HYPD) to reallocate 800,000 HYPE tokens - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | -8 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 1.516e+007 (%) |
| Held by Institutions | 1.004e+007 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 739760 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -7.56 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 63.5 % |
| Return on Equity (ttm) | -33.9 % |
| Qtrly Rev. Growth | 1.04e+006 % |
| Gross Profit (p.s.) | 183.55 |
| Sales Per Share | 122890 |
| EBITDA (p.s.) | -982206 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | -0.35 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 940090 |
| Forward Dividend | 1.12e+006 |
| Dividend Yield | 36296900% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|